Tango‚ a dance that started off in Argentina in the late 1800’s‚ where it developed in the slum of the city has gone through many changes to become one of the most popular styles of music and dance in the world today. The tango developed as a form of entertainment for those rootless African slaves who used the word tango for the drum-based emitting music “tan-go!”. Argentina Tango was first known as forbidden dance because the dance revealed the sexual act between a man and a woman. However
Premium Dance Buenos Aires Social dance
Lewent at Merck & Co.‚ Inc. Ways in which the Financial Area at Merck added value to the company beyond its typical work: * In the 80’s era there was no systematic planning model‚ that’s where Merck felt the need to develop theirs‚ i.e.‚ the research planning model. * They also came up with a simulation planning & hedging model‚ which was very effective as they kept on innovating it. * Merck had a well
Premium Finance Risk Decision making
Executive Summary Merck & Company has been presented with an opportunity to invest $30 million for the purchasing rights of an obesity and high cholesterol lowering drug‚ KL-798 from Kappa Labs. Based on the expected probabilities of success through each product-development phase for this new drug‚ as well as the costs involved‚ the net present value of the project is -$1.16 million and is therefore recommended that Merck passes on the investment. Sensitivity analysis also show that adjusting
Premium Clinical trial Net present value Investment
Merck & Co. Executive Summary Case Study Goal The goal of this case study is to examine the current operations of Merck & Co. Inc. and determine areas of potential concern‚ evaluate the effectiveness of the current business model‚ and propose a plan of action to grow Merck & Co. Inc. to be the largest pharmaceutical company in the world. Methods of Analysis This case study will strive to identify areas of concern and opportunity‚ offer solutions‚ and make projections based upon historic data
Premium Financial ratio Financial ratios Strategic management
Merck: Business Analysis Merck is a flourishing research-driven pharmaceutical company‚ which discovers‚ develops‚ manufacturers‚ and promotes an extensive variety of human and animal health products. Although Merck is one of the biggest pharmaceutical companies of the world‚ they still come across problems today while striving to sustain a lead against its competition. Merck has achieved success with its lengthy history of breakthrough drugs and the development of three significant pharmaceutical
Premium Human resource management Pharmaceutical industry Human resources
CASE 5.1: MERCK ACQUISITION OF MEDCO Abstract Corporate mergers and acquisitions (M&A) have become popular across the globe during the last two decades due to globalization‚ liberalization‚ technological developments‚ and competitive business environment (Fisher & Siburg‚ 2009). The synergistic gains from M&A may result from efficient management‚ economies of scale‚ profitable use of assets‚ exploitation of market power‚ and the use of complementary resources (Mitchell
Premium Pharmacology Pharmaceutical industry Pharmacy
BAB003 7/10/00 Quality at Gillette Argentina Jorge Micozzi‚ President for Latin America of The Gillette Company‚ looked up from the report on Argentina’s Total Quality Management (TQM) program that was going to be delivered to the corporation’s quality council in early 1999. “As you can see from these business measures‚” he told the casewriter‚ “our TQM program has been very successful. This has been my most important program and Victor Walker‚ program manager‚ was the key to its implementation
Premium Total quality management Quality management
A Discussion on the Company’s Decision Making Process‚ Group Behavior and Organizational Structure Abstract Merck is a pharmaceutical and medical researching company that is dealing with managerial challenges in their daily business operations. Their background and their issues regarding the matter will then help one understand how the actual picture of the real accounts of the managerial decision processes that happen to actual multinational company operations. Having been
Premium Corporation Business Company
EXECUTIVE SUMMARY Statement of the Problem Merck & Co.‚ Inc.‚ a leading pharmaceutical company‚ faces the threat of the patents of its most popular drugs expiring in 2002. The only way to counter the loss of sales from these drugs going off patent is to develop new drugs in order to refresh the company’s portfolio. LAB Pharmaceuticals‚ a small pharmaceutical company who specializes in the treatment of neurological disorders‚ has approached Merck with the opportunity to license Davanrik‚ a new
Premium Patent Pharmacology Pharmaceutical drug
| Merck & Company Inc. | Case 1 | | | Introduction of the Company Merck was established in 1891 to improve human and animal health through the development of innovative products. Merck currently has two reportable segments‚ the Pharmaceutical Segment and the Vaccines and Infectious Diseases Segment. Merck sells products through several channels including wholesalers‚ retailers‚ hospitals‚ clinics‚ government and managed health services providers. In the 1980’s the Merck was very
Premium Generic drug Pharmaceutical industry Mergers and acquisitions